Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Brain and Central Nervous System Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT04588246
What this trial is testing

Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+9 more
NRG Oncology 19
Not applicableStudy completedNCT00201903
What this trial is testing

The Roles of Tissue Factor in Malignant Gliomas

Who this might be right for
Venous ThromboembolismBrain Tumors
Ontario Clinical Oncology Group (OCOG) 30
Early research (Phase 1)Study completedNCT00536861
What this trial is testing

Safety Study of Radiotherapy and Concurrent Erlotinib (Tarceva®) for Brain Metastases From a Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerBrain Metastases
Amsterdam UMC, location VUmc 11
Testing effectiveness (Phase 2)Ended earlyNCT02624388
What this trial is testing

Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)

Who this might be right for
LymphomaChildhood LymphomaSolid Tumor+13 more
University of Virginia 4
Testing effectiveness (Phase 2)Ended earlyNCT03352427
What this trial is testing

Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring Platelet-Derived Growth Factor Receptor (PDGFR) Alterations

Who this might be right for
GliomaHigh Grade GliomaPontine Tumors
University of Michigan Rogel Cancer Center 3
Early research (Phase 1)Looking for participantsNCT04510051
What this trial is testing

CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children

Who this might be right for
Malignant Brain NeoplasmRecurrent Malignant Brain NeoplasmRefractory Malignant Brain Neoplasm
City of Hope Medical Center 18
Not applicableStudy completedNCT02023346
What this trial is testing

Prognostic Awareness and Patient-Physician Communication in Malignant Glioma

Who this might be right for
Malignant Glioma
Memorial Sloan Kettering Cancer Center 95
Testing effectiveness (Phase 2)Study completedNCT02632786
What this trial is testing

The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis

Who this might be right for
AL Amyloidosis
Prothena Biosciences Ltd. 129
Testing effectiveness (Phase 2)Study completedNCT00400816
What this trial is testing

Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma

Who this might be right for
Central Nervous System TumorsBrain Tumor
The Cleveland Clinic 29
Not applicableStudy completedNCT03673878
What this trial is testing

Prevalence of a Localized or Diffuse Pruritus in a Population With One or Several, Primitive or Secondary, Brain Tumor(s)

Who this might be right for
PruritusBrain Tumor
University Hospital, Brest 200
Not applicableStudy completedNCT05717335
What this trial is testing

Observational Pilot Study With TachoSil as a Ventricular Sealant

Who this might be right for
Intraventricular Neoplasm
Germans Trias i Pujol Hospital 20
Early research (Phase 1)Active Not RecruitingNCT07118176
What this trial is testing

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

Who this might be right for
Anal CarcinomaBladder CarcinomaBreast Carcinoma+31 more
Jonsson Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00379080
What this trial is testing

Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma

Who this might be right for
Adult Brain TumorAdult Giant Cell GlioblastomaAdult Glioblastoma+2 more
National Cancer Institute (NCI) 60
Not applicableLooking for participantsNCT07396896
What this trial is testing

KETO-TUMOR: a Study on Brain Tumors and Central Obesity

Who this might be right for
Obese PatientsHypothalamic Neoplasms
Meyer Children's Hospital IRCCS 30
Testing effectiveness (Phase 2)Looking for participantsNCT05064280
What this trial is testing

Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases

Who this might be right for
Brain MetastasesTumor
M.D. Anderson Cancer Center 104
Not applicableLooking for participantsNCT00196742
What this trial is testing

Fabry Disease Registry & Pregnancy Sub-registry

Who this might be right for
Fabry Disease
Genzyme, a Sanofi Company 9,000
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Not applicableUnknownNCT03717454
What this trial is testing

Dopamine D2 Receptors(D2R) Imaging in Prolactinomas

Who this might be right for
Prolactinoma
Zhebao Wu 50
Early research (Phase 1)UnknownNCT00003842
What this trial is testing

IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma

Who this might be right for
Brain and Central Nervous System Tumors
Barrett Cancer Center 30
Early research (Phase 1)Study completedNCT00005796
What this trial is testing

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ
Indiana University 10
Next Page